All terms in DRUGBANK

Label Id Description
AZD3409 DB04893 [AZD3409 is a farnesyl-transferase inhibitor (FAR) indicated for the treatment of solid tumors. Phase I trials were initiated January 2003, and were ongoing as of February 2004. As of February 2007 the development of AZD3409 had been discontinued.]
Quinacrine mustard DB02240
3-(5-amino-7-hydroxy-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(3,5-dichlorobenzyl)-benzamide DB03571
8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One DB02241
FR230513 DB03572
Tris-Hydroxymethyl-Methyl-Ammonium DB03570
Lowbush blueberry DB14229 [Ingredient used in over-the-counter medications.]
Lactobacillus helveticus DB14226
24-Homo-1,25-dihydroxyvitamin D3 DB15557 [24-Homo-1,25-dihydroxyvitamin D3 is a novel [vitamin D] analogue.]
Enterococcus faecium DB14225
Zinc glycinate citrate DB15556
Zenocutuzumab DB15559 [Zenocutuzumab is under investigation in clinical trial NCT03321981 (MCLA-128 With Trastuzumab/chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer).]
Threonic acid DB14228
Imalumab DB15558 [Imalumab is under investigation in clinical trial NCT02540356 (Phase 1/2a Two-arm Dose-escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer).]
Technetium Tc-99m DB14227 [Technetium-99m is the metastable isotope of technetium. It is commonly symbolized as 99mTc and used in the area of medical diagnosis. Technetium-99m is the most commonly used medical radioisotope.]
Leptazoline C DB15553 [Leptazoline C is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see [Leptazoline A], [Leptazoline B], and [Leptazoline D].]
Bifidobacterium longum infantis DB14222
Beclomethasone 17-monopropionate DB14221 [An ester of beclomethasone.]
Leptazoline B DB15552 [Leptazoline B is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see [Leptazoline A], [Leptazoline C], and [Leptazoline D].]
Magnesium malate DB15555